Paper41797698
TRIM28 Is an E3 Ligase of IRP2 Suppressing Ischemia/Reperfusion-Induced Myocardial Ferroptosis.
Zhu K and 21 others. Circulation, 2026. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. TRIM28 Is an E3 Ligase of IRP2 Suppressing Ischemia/Reperfusion-Induced Myocardial Ferroptosis. Papers, record 41797698. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41797698
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- TRIM28 Is an E3 Ligase of IRP2 Suppressing Ischemia/Reperfusion-Induced Myocardial Ferroptosis.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ferroptosis | Major topic |
| Myocardial Reperfusion Injury | Major topic |
| Tripartite Motif-Containing Protein 28 | Major topic |
| Myocytes, Cardiac | Major topic |
| Ubiquitin-Protein Ligases | Major topic |
| Animals | |
| Humans | |
| Mice | |
| Rats | |
| Mice, Knockout | |
| Male | |
| Mice, Inbred C57BL | |
| Rats, Sprague-Dawley |
Source PubMed
References72
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33537073 | Ferroptosis as a novel therapeutic target for cardiovascular disease. | Theranostics | 2021 | https://conductscience.org/library/papers/33537073 | PubMed |
| 2 | 40302259 | Resveratrol Alleviates Ischemia-Reperfusion-Induced Neuronal Damage by Inhibiting NR3C2-Mediated TRIM28 Expression. | J Integr Neurosci | 2025 | https://conductscience.org/library/papers/40302259 | PubMed |
| 3 | 33398366 | Zenglv Fumai Granule protects cardiomyocytes against hypoxia/reoxygenation-induced apoptosis via inhibiting TRIM28 expression. | Mol Med Rep | 2021 | https://conductscience.org/library/papers/33398366 | PubMed |
| 4 | 20075919 | KAP1 controls endogenous retroviruses in embryonic stem cells. | Nature | 2010 | https://conductscience.org/library/papers/20075919 | PubMed |
| 5 | 31245788 | Metabolic signatures of cancer cells and stem cells. | Nat Metab | 2019 | https://conductscience.org/library/papers/31245788 | PubMed |
| 6 | 25650368 | Perhexiline: lessons for heart failure therapeutics. | JACC Heart Fail | 2015 | https://conductscience.org/library/papers/25650368 | PubMed |
| 7 | 37783783 | Mechanisms controlling cellular and systemic iron homeostasis. | Nat Rev Mol Cell Biol | 2024 | https://conductscience.org/library/papers/37783783 | PubMed |
| 8 | 34583519 | Integrated Stress Response Couples Mitochondrial Protein Translation With Oxidative Stress Control. | Circulation | 2021 | https://conductscience.org/library/papers/34583519 | PubMed |
| 9 | 28851455 | The complexity of TRIM28 contribution to cancer. | J Biomed Sci | 2017 | https://conductscience.org/library/papers/28851455 | PubMed |
| 10 | 30204128 | Inadequate ubiquitination-proteasome coupling contributes to myocardial ischemia-reperfusion injury. | J Clin Invest | 2018 | https://conductscience.org/library/papers/30204128 | PubMed |
| 11 | 23354051 | Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders. | Nature | 2013 | https://conductscience.org/library/papers/23354051 | PubMed |
| 12 | 20921436 | Perhexiline and hypertrophic cardiomyopathy: a new horizon for metabolic modulation. | Circulation | 2010 | https://conductscience.org/library/papers/20921436 | PubMed |
| 13 | 37981501 | Regulated cell death in myocardial ischemia-reperfusion injury. | Trends Endocrinol Metab | 2024 | https://conductscience.org/library/papers/37981501 | PubMed |
| 14 | 11959841 | SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. | Genes Dev | 2002 | https://conductscience.org/library/papers/11959841 | PubMed |
| 15 | 35788564 | The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease. | Nat Rev Cardiol | 2023 | https://conductscience.org/library/papers/35788564 | PubMed |
| 16 | 25516281 | Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. | Genome Biol | 2014 | https://conductscience.org/library/papers/25516281 | PubMed |
| 17 | 33118835 | Myocardial Gene Expression Signatures in Human Heart Failure With Preserved Ejection Fraction. | Circulation | 2021 | https://conductscience.org/library/papers/33118835 | PubMed |
| 18 | 25388664 | Identification of PI3K regulatory subunit p55γ as a novel inhibitor of vascular smooth muscle cell proliferation and neointimal formation. | Cardiovasc Res | 2015 | https://conductscience.org/library/papers/25388664 | PubMed |
| 19 | 35783854 | Alterations of Cardiac Protein Kinases in Cyclic Nucleotide-Dependent Signaling Pathways in Human Ischemic Heart Failure. | Front Cardiovasc Med | 2022 | https://conductscience.org/library/papers/35783854 | PubMed |
| 20 | 37392421 | Cardiac lipid metabolism, mitochondrial function, and heart failure. | Cardiovasc Res | 2023 | https://conductscience.org/library/papers/37392421 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42723477 | FTH1 mRNA-Protein Discordance in Cardiac Ferroptosis: Multilayer Posttranscriptional and Degradative Control. | Cardiovasc Ther | 2026 | https://conductscience.org/library/papers/42723477 | PubMed |
| 42290584 | TRIM24 in Human Cancers: A Dual-Function Oncoprotein, Regulatory Mechanisms, and Emerging Therapeutic Strategies. | Int J Cancer | 2026 | https://conductscience.org/library/papers/42290584 | PubMed |
| 42194066 | TIF1 Family Proteins as Modulators of Cell Death: Mechanisms and Therapeutic Opportunities. | Biomolecules | 2026 | https://conductscience.org/library/papers/42194066 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CBLL2 | 158506 | PubTator's text mining | https://conductscience.org/library/genes/158506 | NCBI Gene |
| IREB2 | 3658 | PubTator's text mining | https://conductscience.org/library/genes/3658 | NCBI Gene |
| PIK3R3 | 8503 | PubTator's text mining | https://conductscience.org/library/genes/8503 | NCBI Gene |
| TFRC | 7037 | PubTator's text mining | https://conductscience.org/library/genes/7037 | NCBI Gene |
| TRIM28 | 10155 | PubTator's text mining | https://conductscience.org/library/genes/10155 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41797698
GET https://conductscience.org/api/papers/v1/41797698/authors?page=2